Blood test may personalize ovarian cancer care after surgery
NCT ID NCT07546578
First seen Apr 28, 2026 · Last updated Jun 22, 2026 · Updated 12 times
Summary
This study is testing whether a blood test that looks for tiny bits of tumor DNA (called ctDNA) can help doctors decide who needs extra treatment after ovarian cancer surgery. Researchers will analyze stored blood samples from 50 patients taken before and after surgery. The goal is to see if the test can spot patients at higher risk of the cancer coming back, which could lead to more personalized care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Policlinico Universitario A. Gemelli IRCCS
Roma, Italy
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ctDNA blood test (liquid biopsy)
What this could lead to
If successful, this could lead to a more personalized approach to decide who needs chemotherapy after ovarian cancer surgery, potentially avoiding unnecessary treatment.
What could go wrong
This is a small, retrospective study using stored samples, not a treatment trial. It may not prove that ctDNA testing improves outcomes, and results may not apply to all patients.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.